Bertil Casslén (Former)
21 – 30 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
(
- Contribution to journal › Article
-
Mark
Nove matrix metaloproteinazy v cyklickem endometriu
(
- Contribution to journal › Article
-
Mark
Profily endometrialni exprese mRNA u vybranych matrix metaloproteinaz a tkanoveho inhibitoru metaloproteinaz-1
(
- Contribution to journal › Article
-
Mark
Exprese MMP-26 v endometrialnich explantech pod vlivem estradiolu a progesteronu
(
- Contribution to journal › Article
-
Mark
Norepinephrine Transporter (NET), Serotonin Transporter (SERT), Vesicular Monoamine Transporter (VMAT2) and Organic Cation Transporters (OCT1, 2 and EMT) in Human Placenta from Pre-eclamptic and Normotensive Pregnancies.
(
- Contribution to journal › Article
- 2003
-
Mark
Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium
(
- Contribution to journal › Article
-
Mark
High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer.
(
- Contribution to journal › Article
-
Mark
Plasma membrane and vesicular monoamine transporters in normal endometrium and early pregnancy decidua.
(
- Contribution to journal › Article
-
Mark
High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer
(
- Contribution to journal › Article
- 2002
-
Mark
High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.
(
- Contribution to journal › Article